ArticleTherapeutic advances in endocrinology and metabolism2022

Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?

Nadia Sawicka-Gutaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.